Partner Headlines - PGNX

  1. Tiger Management's Julian Robertson Buys Alibaba, eBay, MasTec, ...

    GuruFocus
  2. Ex-Boxer Paul Tudor Jones Delivering Knockout Punches on Wall ...

    GuruFocus
  3. Morning Market Movers

    Benzinga
  4. Earnings Scheduled For November 7, 2014

    Benzinga
  5. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR ...

    Benzinga
  6. Morning Market Losers

    Benzinga
  7. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  8. Earnings Scheduled For August 8, 2014

    Benzinga
  9. Morning Market Movers

    Benzinga
  10. Benzinga's Top #PreMarket Gainers

    Benzinga
  11. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  12. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation ...

    Benzinga
  13. Progenics Announces Will Host Call Related to FDA Appeal Response ...

    Benzinga
  14. Progenics, Nektar Still Halted; FDA Advisory Committee Expected ...

    Benzinga
  15. Small Pharmaceuticals Rallying Following FDA Report

    Benzinga
  16. Mid-Afternoon Market Update; Hertz Down, QuikSilver Gain On CEO ...

    Benzinga
  17. Mid-Day Market Update: Diamond Foods Shares Fall After Weak Earnings; ...

    Benzinga
  18. Earnings Scheduled For May 9, 2014

    Benzinga
  19. Progenics Pharmaceuticals Announces Completion of Enrollment ...

    Benzinga
  20. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  21. Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the ...

    Benzinga
  22. Earnings Scheduled For March 13, 2014

    Benzinga
  23. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  24. Progenics Pharmaceuticals Announces the Appointment of Karen ...

    Benzinga
  25. Progenics Pharmaceuticals Relaunches Registrational Trial of ...

    Benzinga
  26. Earnings Scheduled For November 11, 2013

    Benzinga
  27. Salix Pharmaceuticals Thrives With Promising GI Drugs

    IBD
  28. Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX

    GuruFocus
  29. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  30. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  31. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  32. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  33. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  34. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  35. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  36. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  37. Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX

    GuruFocus
  38. Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Robert Baker buys ...

    GuruFocus
  39. 5 Stocks That Dropped the Most Since Gurus Bought Them

    GuruFocus
  40. EZchip Semiconductor, Sagent Pharmaceuticals Among Stocks setting ...

    FoxBusiness
  41. Salix trounces Q2 estimates

    IBD
  42. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  43. Salix Pharmaceuticals Beats, Announces Licensing Deal

    IBD
  44. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily ...

    FoxBusiness
  45. Stocks Finish Little Changed Ahead of Central Bank Meetings with ...

    MarketIntelligenceCenter
  46. Salix, Progenics Stocks Fall On Drug Approval Delay

    IBD
  47. Stock Futures Mixed; Salix, Progenics Tumble

    IBD
  48. Benzinga's Top Pre-Market Losers

    Benzinga
  49. Financial Breakfast: Morning News Summary for July 30, 2012

    Benzinga
  50. Salix Q1 Results Beat Estimates; Raises EPS Guidance

    IBD
  51. Microcap Movers for Tuesday December 20, 2011

    Benzinga
  52. Stocks Bounce Back In Big Volume

    IBD
  53. Progenics Pharma Up 30% on Positive Phase 3 Results

    Benzinga
  54. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
  55. Morning Market Movers

    Benzinga
  56. Progenics Pharmaceuticals Lures Call Players in the Options Pits

    SchaeffersResearch
  57. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
Trading Center